Pyridostigmine prevents peripheral vascular endothelial dysfunction in rats with myocardial infarction

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 3, 2014, Pages 202-209

  Qin, Fangfang ^a   Lu, Yi ^a   He, Xi ^a   Zhao, Ming ^a   Bi, Xueyuan ^a   Yu, Xiaojiang ^a   Liu, Jinjun ^a   Zang, Wei jin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Endothelial dysfunction; Myocardial infarction; Nitric oxide; Pyridostigmine; Reactive oxygen species

Indexed keywords

MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PYRIDOSTIGMINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG BIOAVAILABILITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE RELAXATION; HEART RATE VARIABILITY; MALE; MESENTERIC ARTERY; NONHUMAN; OXIDATIVE STRESS; PARASYMPATHETIC FUNCTION; PERIPHERAL VASCULAR ENDOTHELIAL DYSFUNCTION; PERIPHERAL VASCULAR SYSTEM; PRESSORECEPTOR REFLEX; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; VAGUS NERVE STIMULATION; VASCULAR RESISTANCE;

ENDOTHELIAL DYSFUNCTION; MYOCARDIAL INFARCTION; NITRIC OXIDE; PYRIDOSTIGMINE; REACTIVE OXYGEN SPECIES;

ANIMALS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PYRIDOSTIGMINE BROMIDE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 84896367566     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12198     Document Type: Article

References (32)

1. Devaux C, Iglarz M, Richard V et al. Chronic decrease in flow contributes to heart failure-induced endothelial dysfunction in rats. Clin. Exp. Pharmacol. Physiol. 2004; 31: 302-5.
2. Vercauteren M, Remy E, Devaux C et al. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 2006; 114: 2498-507.
3. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 2009; 81: 457-64.
4. Datla SR, Griendling KK. Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 2010; 56: 325-30.
5. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000; 87: 840-4.
6. Mulders AC, Mathy MJ, Meyer ZHD et al. Activation of sphingosine kinase by muscarinic receptors enhances NO-mediated and attenuates EDHF-mediated vasorelaxation. Basic Res. Cardiol. 2009; 104: 50-9.
7. Vita JA. Endothelial function. Circulation 2011; 124: e906-12.
8. Wang Y, Wang S, Wier WG et al. Exercise improves the dilatation function of mesenteric arteries in postmyocardial infarction rats via a PI3K/Akt/eNOS pathway-mediated mechanism. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H2097-106.
9. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J. Am. Coll. Cardiol. 1993; 22: A72-84.
10. Bristow MR, Gilbert EM, Abraham WT et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996; 94: 2807-16.
11. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 2001; 345: 1667-75.
12. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-4.
13. Kong SS, Liu JJ, Yu XJ, Lu Y, Zang WJ. Protection against ischemia-induced oxidative stress conferred by vagal stimulation in the rat heart: Involvement of the AMPK-PKC Pathway. Int. J. Mol. Sci. 2012; 13: 14311-25.
14. Okazaki Y, Zheng C, Li M, Sugimachi M. Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure. J. Physiol. Sci. 2010; 60: 67-74.
15. Kong SS, Liu JJ, Hwang TC, Yu XJ, Lu Y, Zang WJ. Tumour necrosis factor-alpha and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Clin. Exp. Pharmacol. Physiol. 2011; 38: 300-6.
16. Yu JG, Song SW, Shu H et al. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine-{alpha}7-nicotinic ACh receptor in rats. Eur. Heart J. 2011; 34: 2412-20.
17. Soares PP, Nóbrega AC, Ushizima MR, Irigoyen MC. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton. Neurosci. 2004; 113: 24-31.
18. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-92.
19. Wang S, Zhang Y, Wier WG et al. Role of store-operated Ca(2+) entry in adenosine-induced vasodilatation of rat small mesenteric artery. Am. J. Physiol. Heart Circ. Physiol. 2009; 297: H347-54.
20. Somers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 2000; 101: 1722-8.
21. Obata JE, Nakamura T, Kitta Y et al. Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery. Circ. Cardiovasc. Interv. 2009; 2: 384-91.
22. Kim JW, Seo HS, Park JH et al. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus-versus a sirolimus-eluting stent: Differential recovery of coronary endothelial dysfunction. J. Am. Coll. Cardiol. 2009; 53: 1653-9.
23. Lataro RM, Silva CA, Fazan RJ et al. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013; 305: R908-16.
24. Sabino JP, Silva CA, Giusti H, Glass ML, Salgado HC, Fazan RJ. Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats. Auton. Neurosci. 2013; 179: 43-8.
25. Xu Y, Henning RH, Lipsic E, van Buiten A, van Gilst WH, Buikema H. Acetylcholine stimulated dilatation and stretch induced myogenic constriction in mesenteric artery of rats with chronic heart failure. Eur. J. Heart Fail. 2007; 9: 144-51.
26. 1 receptor blockade. Br. J. Pharmacol. 2003; 139: 1317-25.
27. Bi XY, He X, Zhao M, Yu XJ, Zang WJ. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury. J. Cardiovasc. Pharmacol. 2013; 61: 391-400.
28. He X, Zhao M, Bi XY, Yu XJ, Zang WJ. Delayed preconditioning prevents ischemia/reperfusion-induced endothelial injury in rats: Role of ROS and ENOS. Lab. Invest. 2013; 93: 168-80.
29. Brack KE, Patel VH, Mantravardi R, Coote JH, Ng GA. Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J. Physiol. 2009; 587: 3045-54.
30. Li W, Olshansky B. Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail. Rev. 2011; 16: 137-45.
31. Feletou M, Vanhoutte PM. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H985-1002.
32. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 1999; 100: 292-8.